<DOC>
	<DOCNO>NCT00004564</DOCNO>
	<brief_summary>The objective study determine action drug call clopidogrel , start taking , decrease another drug call atorvastatin , also start take . Clopidogrel oral antiplatelet agent show prevent stroke heart attack . Atorvastatin cholesterol lower agent . Twenty adult 18-75 year age require cholesterol-lowering agent antiplatelet agent therapy recruit study cardiology clinic visitation . In one group , antiplatelet agent ( clopidogrel ) regimen administer first , follow cholesterol-lowering medication ( atorvastatin ) . In second group , atorvastatin administer first , follow clopidogrel . A new test call erythromycin breath test administer three time study measure liver metabolize drug . Blood sample also obtain assess platelet function . The criteria exclusion patient refusal inability give write consent , patient allergic reaction erythromycin , patient know bleed problem , liver disease , significant lung disease kidney disease pregnancy . Patients psychiatric impairment document history substance abuse also exclude study .</brief_summary>
	<brief_title>The Inhibition Platelet Antiaggregating Activity Clopidogrel Atorvastatin Detected Erythromycin Breath Test : Metabolic Inhibition Hepatic Cytochrome P450-3A</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Males female age 1875 year age without bias racial ethnic background , undergo percutaneous coronary intervention require antiplatelet therapy : 1 . Patients present cardiology clinic require cholesterol lower agent 2 . Patients present cardiology clinic require antiplatelet agent . Refusal inability give write consent Allergic reaction erythromycin Have know bleeding problem , liver disease , significant lung disease kidney disease Pregnancy Psychiatric impairment document history substance abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>Platelet Aggregation Inhibitors</keyword>
	<keyword>Cerebrovascular accident</keyword>
</DOC>